Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05588193 · ClinicalTrials.gov registry record · NA
ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments
A NA study of HIV, sponsored by Albert Einstein College of Medicine.
- Active
- Registry status
- NA
- Development phase
- 1,560
- Enrollment target
- 2
- Study locations
NCT05588193 is a NA study of HIV that is active but no longer recruiting, run by Albert Einstein College of Medicine. The registered enrollment target is 1,560 participants, above the 435-participant average among 303 other HIV trials with a reported enrollment target (259% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT05588193, a NA study of HIV, is active but no longer recruiting, sponsored by Albert Einstein College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,560 participants
- Enrollment target
- 2
- Study locations
Study Summary
Severe inequities in HIV pre-exposure prophylaxis (PrEP) access and use in communities hardest hit by the HIV epidemic persist, further exacerbating ongoing racial/ethnic and socioeconomic disparities in HIV incidence. In these same communities, many patients at risk for HIV seek care for sexually transmitted infections (STIs) in Emergency Departments (EDs), but the structure of traditional ED care is poorly suited to address HIV prevention or provide PrEP. To advance the Prevent objective of the Ending the HIV Epidemic (EHE) initiative, ED2PrEP will leverage an implementation science approach to rigorously test two innovative strategies for increasing PrEP uptake among patients seeking STI care in EDs in one of the 48 EHE-identified geographic hotspots.
Conditions Studied
Interventions
- BEHAVIORAL PVO
- BEHAVIORAL TSH
Study Locations (2)
New York
- City University of New York - Hunter College - New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,560 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2026-11-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05588193
The ClinicalTrials.gov registry entry for NCT05588193 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,560 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 435-participant average among 303 other HIV trials with a reported enrollment target (259% higher). The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which PVO is the first listed.
NCT05588193 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05588193 about?
NCT05588193 is a clinical study titled "ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments". Severe inequities in HIV pre-exposure prophylaxis (PrEP) access and use in communities hardest hit by the HIV epidemic persist, further exacerbating ongoing racial/ethnic and socioeconomic disparities in HIV incidence. In these same communities, many patients at risk for HIV seek care for sexually t...
What is the current status of trial NCT05588193?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,560 participants. The study started on 2024-10-01. Estimated completion is 2026-11-13.
What conditions does trial NCT05588193 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT05588193?
The interventions under investigation include: PVO (BEHAVIORAL), TSH (BEHAVIORAL).
Who is sponsoring clinical trial NCT05588193?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05588193 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.